Section II
2151 – 2160 of 8764
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
(
- Contribution to journal › Scientific review
-
Mark
Interventions for treatment of COVID-19 : A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
(
- Contribution to journal › Article
-
Mark
Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma
(
- Contribution to journal › Scientific review
-
Mark
Underlying contributing conditions to breathlessness among middle-aged individuals in the general population : A cross-sectional study
(
- Contribution to journal › Article
-
Mark
Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy : a registry-based study
(
- Contribution to journal › Article
-
Mark
Association of coronary calcium score with endothelial dysfunction and arterial stiffness
(
- Contribution to journal › Article
-
Mark
Improving pandemic preparedness and management : Lessons learned and ways forward : independent expert report
2020)(
- Book/Report › Report
-
Mark
Management and risk of mortality in patients hospitalised due to a first severe COPD exacerbation
(
- Contribution to journal › Article
-
Mark
The Swedish National Airway Register (SNAR) : development, design and utility to date
(
- Contribution to journal › Article
-
Mark
Using proximity extension proteomics assay to identify biomarkers associated with infarct size and ejection fraction after ST-elevation myocardial infarction
(
- Contribution to journal › Article